Mosunetuzumab for the treatment of follicular lymphoma-Reference-Cited by-同舟云学术

Mosunetuzumab for the treatment of follicular lymphoma

Published:2024-09-11 Issue: Volume: Page:
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Labanca Caterina¹,Martino Enrica Antonia¹,Vigna Ernesto¹,Bruzzese Antonella¹,Mendicino Francesco¹,De Luca Paola¹,Lucia Eugenio¹,Olivito Virginia¹,Fragliasso Valentina²,Neri Antonino³,Morabito Fortunato⁴,Gentile Massimo¹⁵

Affiliation:

1. Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy

2. Laboratorio di Ricerca Traslazionale Azienda USL-IRCSS Reggio Emilia, Emilia-Romagna, Italy

3. Scientific Directorate IRCCS of Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy

4. Gruppo Amici Dell’Ematologia Foundation-GrADE, Reggio Emilia, Italy

5. Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy

Funder

Ministry of Health

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2024.2404079

Reference56 articles.

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

2. Update on follicular lymphoma

3. Non-Hodgkin’s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma;Blood, Am. J. Hematol,1997

4. Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry

5. Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up